Denosumab Superior for Preventing Skeletal Complications in Advanced Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
Denosumab Versus Zoledronic Acid for Treatment of Bone Metastases in Men With Castration-Resistant Prostate Cancer: A Randomised, Double-Blind Study
Lancet 2011 Mar 05;377(9768)813-822, K Fizazi, M Carducci, M Smith, R Damião, J Brown, L Karsh, P Milecki, N Shore, M Rader, H Wang, Q Jiang, S Tadros, R Dansey, C GoesslAdvanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.